Login

Introducing YESCan: Streamlining Fenestration Product Data Submission to NRCan | Valmor Ruscheck - CEO of Natural Resources Canada 00:10:00

Share On Facebook Share On Twitter

Valmor Ruscheck is the CEO of Natural Resources Canada

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
TJ Rodgers: Capitalism, Environmentalism, and Corporate Responsibility|T. J. Rodgers
00:10:00
Egan Street Resources: Advancing the Rothsay Gold Project in Western Australia
00:10:00
Western Australian Manganese Developer Poised for High-Purity Market Entry
00:10:00
Empowering Women in the Workplace: Career Insights from Anjie Peña Kallas and Abby Groom at T. Rowe Price
00:10:00
Collins Aerospace Retirement Benefits: A Comprehensive Guide
00:10:00
Insights on Upstream Consolidation and Redetermination Trends from Keith Buchanan"
00:10:00
Interview with EXPRO for ADIPEC 2023 | MIKE JORDAN, CEO, BOARD MEMBER, EXPRO GROUP HOLDINGS
00:10:00
Nollium Bryan: Lithium Exploration and Resource Development in Northwest Argentina
00:10:00
"Top 20 Money Questions Answered | Terry Savage & Ed Gjertsen Discuss Financial Planning Insights"
00:10:00
Climate Resilience Panel at Infraday Florida | Allan Marks - Partner of Milbank LLP
00:10:00
Anders Johansson Discusses Fortinova's Growth and Future Plans | Anders Johansson, CEO, Fortinova Fastigheter AB.
00:10:00
Accelerating biomedical innovation by connecting science finance and commerce|Dr Suzanne Dilly,Chief Executive Officer,ValiRx

© 2017 - Neuhu+